1. Home
  2. SUPV vs ABCL Comparison

SUPV vs ABCL Comparison

Compare SUPV & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

HOLD

Current Price

$11.43

Market Cap

927.1M

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.12

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPV
ABCL
Founded
1887
2012
Country
Argentina
Canada
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
927.1M
1.1B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
SUPV
ABCL
Price
$11.43
$4.12
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$13.33
$7.75
AVG Volume (30 Days)
1.1M
3.4M
Earning Date
11-25-2025
02-26-2026
Dividend Yield
1.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$467,987,272.00
$35,325,000.00
Revenue This Year
$12.75
$25.45
Revenue Next Year
$45.23
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$4.54
$1.89
52 Week High
$19.75
$6.52

Technical Indicators

Market Signals
Indicator
SUPV
ABCL
Relative Strength Index (RSI) 51.01 63.25
Support Level $11.05 $3.34
Resistance Level $12.48 $3.82
Average True Range (ATR) 0.63 0.21
MACD -0.08 0.07
Stochastic Oscillator 41.32 89.20

Price Performance

Historical Comparison
SUPV
ABCL

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: